Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.
Hematology Department, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. hampig.kourie@hotmail.com.
Hampig Raphael
HR
Kourie
Data Centre, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.
Lieveke
L
Ameye
Data Centre, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.
Marianne
M
Paesmans
Hematology Department, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.
Dominique
D
Bron
D037282:Calreticulin / Q000235:genetics*; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000473:pathology; D005355:Fibrosis / Q000175:diagnosis / Q000235:genetics / Q000401:mortality; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D007938:Leukemia / Q000175:diagnosis / Q000235:genetics* / Q000401:mortality; D009154:Mutation / Q000235:genetics*; D011379:Prognosis; D013163:Splenomegaly / Q000175:diagnosis / Q000235:genetics* / Q000401:mortality; D015996:Survival Rate / Q000639:trends; D013927:Thrombosis / Q000175:diagnosis / Q000235:genetics* / Q000401:mortality
D037282:Calreticulin; C507924:JAK2 protein, human; D053614:Janus Kinase 2